The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
At least the forecast inventory unwind will create additional
Free cash flow
EBITDA outlook re cash
Being the only Independent supplier in the world must surely carry a massive value premium..
Having read the results in detail there is no new historic news other than a non cash ECL of £0.5m, everything is confirmation of previous guidance. The outlook and forward visibility is the key positive.
iMHo DYOR
Phew !!! Excellent results and outlook and strong cash position. IMHO DYOR
That is an old announcement - haven’t seen any release confirming results date… Cheers
Year End Results- anyone got any news or contacted company for an update ??
Which day are results - Thursday ? was there a results date RNS ?
When are the final results announced ?
Great news - hopefully a lot more to come.
Hopefully we will hear more with the results on where they are at on restructuring the company divisionally that would facilitate carve out and separate valuation or potential take over of different parts of the business. This seems a sensible move for shareholders. Any view or knowledge
on this ? Maybe already relatively separate ? IMHO SYOR
Good to hear robust future news flow expected in this sector of the business.
https://www.proactiveinvestors.co.uk/companies/news/983203/kromek-group-boss-arnab-basu-tells-investors-to-expect-robust-news-flow-983203.html
New order, excellent news and endorsement . These individually aren’t huge but are cumulative…
Historic share price barriers seem to be around 16p then 21p then 28p IMHO DYOR. Any views on share price barriers in short / medium term and whether we are likely to test them again ?? or will share price remain subdued for some time ?
Anyone know who the main investors are now in Kromek ? I think about 35% held by small private investors ??
Thanks that is very helpful. The Phillips situation is very interesting….
In June 21 Kromek were awarded a 28 month contract to develop the pathogen detection system for DARPA.
This is due to end around December 23 and if delivered to that timescale is a game changer. All signs on track but we will see when the results are announced. In the meantime stars are aligning for the core parts of the business and we need some more material contracts in 2022 to move forward. A major bit of comfort was the strong cash position in the last update which I think is driving a bit more confidence. I agree a rally to 14p could well be the limit ahead of a confidence booster IMHO DYOR
https://www.kromek.com/news/rethinking-our-readiness-whitepaper-authored-by-experts-in-the-field/
Is it likely to also make the printed version of IC and if so when is it published? Readership copies c30,000 I think.
Am disappointed with managements lack of update on pathogen detection but hopefully means commercial discussions in progress but who knows !!??